一种稠环化合物、其制备方法和应用

Fused-ring compounds were prepared by extraction from Aspergillus pseudomorphus fermentation broth and separation by high-performance liquid chromatography, which solved the problem of the single structure of existing anti-colorectal cancer compounds and achieved effective inhibition and apoptosis induction of colorectal cancer cells, showing broad prospects for drug application.

CN117384181BActive Publication Date: 2026-07-17WUHAN UNIV OF SCI & TECH +1

Patent Information

Authority / Receiving Office
CN · China
Patent Type
Patents(China)
Current Assignee / Owner
WUHAN UNIV OF SCI & TECH
Filing Date
2023-09-06
Publication Date
2026-07-17

AI Technical Summary

Technical Problem

Existing compounds for treating colorectal cancer have relatively simple structures, exhibit severe chemotherapy resistance, and lack effective new drugs.

Method used

A fused-ring compound and its pharmaceutically acceptable salt are provided, which are prepared by extraction from Aspergillus pseudoepiplo fermentation broth, silica gel column chromatography and high performance liquid chromatography. The preparation method is convenient and has high purity. It can be used to inhibit the proliferation and migration of colorectal cancer cells and induce apoptosis.

Benefits of technology

Compound 1 or its pharmaceutically acceptable salt can significantly inhibit the proliferation and migration of colorectal cancer cells and induce apoptosis, exhibiting good anti-colorectal cancer activity and is suitable for new drug development.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN117384181B_ABST
    Figure CN117384181B_ABST
Patent Text Reader

Abstract

本发明公开了一种稠环化合物、其制备方法和应用。本发明提供了一种具有如下结构的化合物1或其药学上可接受的盐,本发明提供的化合物1或其药学上可接受的盐能够有效抑制结直肠癌HCT‑8细胞的增殖、迁移能力并诱导结直肠癌细胞的凋亡,具有良好的抗结直肠癌活性。
Need to check novelty before this filing date? Find Prior Art